Treating Bone Loss Ups Survival for Patients With Breast Cancer
Long-term data from a trial of adjuvant denosumab in patients with breast cancer suggest a survival benefit in addition to reduced fractures and increased bone density.
United States Michael Gnant American Society Of Clinical Oncology University Of Vienna Breast Cancer American Society
Source: medscape.com